PT Merck Tbk (ISX:MERK) Ending Cash Position: Rp328,000 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MERK PT Merck Tbk ISX:MERK
78 GF Score
Price Rp3,910.00
GF Value Rp4,928.13
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Merck Tbk Ending Cash Position?

PT Merck Tbk ISX:MERK -0.26% 78 Ending Cash Position is Rp328,000 Mil as of Jun. 2026. GuruFocus rates ISX:MERK with a GF Score™ of 78/100 and a GF Value™ of Rp4,928.13 (Modestly Undervalued). The stock has 2 warning signs investors should review.

PT Merck Tbk's Ending Cash Position for the quarter that ended in Jun. 2026 was Rp328,000 Mil.

PT Merck Tbk's quarterly Ending Cash Position increased from Dec. 2025 (Rp363,850 Mil) to Mar. 2026 (Rp443,140 Mil) but then declined from Mar. 2026 (Rp443,140 Mil) to Jun. 2026 (Rp328,000 Mil).

PT Merck Tbk's annual Ending Cash Position declined from Dec. 2023 (Rp201,437 Mil) to Dec. 2024 (Rp87,684 Mil) but then increased from Dec. 2024 (Rp87,684 Mil) to Dec. 2025 (Rp363,850 Mil).

PT Merck Tbk Ending Cash Position Related Terms

PT Merck Tbk Ending Cash Position Historical Data

* Premium members only.

The historical data trend for PT Merck Tbk's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Merck Tbk Ending Cash Position Chart

PT Merck Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 196,342.99 170,428.30 201,436.83 87,684.18 363,850.01

PT Merck Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 237,929.93 171,794.64 363,850.01 443,140.18 328,000.00
ISX:MERK
78GF Score
PT Merck Tbk ISX:MERK
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Merck Tbk Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PT Merck Tbk's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=87684.178+276165.833
=363,850

PT Merck Tbk's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=443140.175+-115140.175
=328,000

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of Rp328,000 Mil mean?
PT Merck Tbk (ISX:MERK) has a Ending Cash Position of Rp328,000 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Merck Tbk and its competitors.
Is PT Merck Tbk's Ending Cash Position too high?
PT Merck Tbk's current Ending Cash Position is Rp328,000 Mil. Overall, PT Merck Tbk has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Merck Tbk's Ending Cash Position compare to ZTS and UTHR?
PT Merck Tbk's Ending Cash Position of Rp328,000 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Merck Tbk and its competitors. PT Merck Tbk's current Ending Cash Position is Rp328,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Merck Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Merck Tbk (ISX:MERK) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp4,928.13, compared to a current price of Rp3,910.00 — trading 20.7% below its estimated fair value. The current Ending Cash Position is Rp328,000 Mil. PT Merck Tbk's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For PT Merck Tbk (ISX:MERK), the current Ending Cash Position is Rp328,000 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Merck Tbk (ISX:MERK) Overvalued in 2026?

Based on GuruFocus' analysis, PT Merck Tbk stock appears to be undervalued. The current stock price of Rp3,910.00 is trading 20.7% below its estimated GF Value™ of Rp4,928.13. GuruFocus considers PT Merck Tbk to be Modestly Undervalued.

Key valuation signals for ISX:MERK:

  • Ending Cash Position: Rp328,000 Mil
  • GF Value™: Rp4,928.13 vs. price of Rp3,910.00 (20.7% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the ISX:MERK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Merck Tbk Business Description

Address Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.
78GF Score

Get the complete analysis for ISX:MERK

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp3,910.00
Price
Rp4,928.13
GF Value